D-1500-2016 Class II Terminated

Recalled by Hospira Inc. — Lake Forest, IL

FDA drug recall D-1500-2016 was initiated by Hospira Inc. on Aug 15, 2016 and is designated Class II. Reason for recall: Discoloration: Firm received complaints of product discoloration and particulates. The recall status is terminated (terminated Aug 23, 2019). Affected quantity: 24000 vials.

Recall details

Product Type
Drugs
Report Date
Sep 21, 2016
Initiation Date
Aug 15, 2016
Termination Date
Aug 23, 2019
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
24000 vials

Product description

DOBUTamine Injection, USP 250 mg/20 mL, 20 mL Vial, For IV Use Only, Must be Diluted Prior to Use, (12.5 mg per mL), Rx Only, Hospira, Inc., Lake Forest, IL 60045 USA, NDC 0409-2025-20

Reason for recall

Discoloration: Firm received complaints of product discoloration and particulates.

Distribution pattern

Product was distributed nationwide. 23700 units distributed to US and Puerto Rico, and Bahamas was 300 units. 30 units returned by customer and destroyed internally.

Code information

Lot #: 52175DD, Exp 01 Oct 2016

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1500-2016
openFDA file date
Nov 19, 2026
Loaded by RegDataLab
Nov 20, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Need the full FDA record for Hospira Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Source: openFDA record for D-1500-2016. Report a data issue: hello@regdatalab.com.